Entering text into the input field will update the search result below

Inovio Pharmaceuticals GAAP EPS of -$1.45 misses by $0.19, revenue of $1.77M beats by $0.31M

Mar. 01, 2022 4:11 PM ETInovio Pharmaceuticals, Inc. (INO)By: Pranav Ghumatkar, SA News Editor1 Comment
  • Inovio Pharmaceuticals press release (NASDAQ:INO): FY GAAP EPS of -$1.45 misses by $0.19.
  • Revenue of $1.77M (-76.1% Y/Y) beats by $0.31M.
  • Shares -5.56%.
  • As of December 31, 2021, cash and cash equivalents and short-term investments were $401.3 million compared to $411.6 million as of

Recommended For You

Comments (1)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

smikhail profile picture
"Because the World Can't Wait."
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.